ClinicalTrials.Veeva

Menu

Role of RDW as Anon Invasive Index for Predicting Liver Cell Failure and Portal Hypertension in Cirrhotic Patient

A

Assiut University

Status

Unknown

Conditions

Predicting Liver Cell Failure & Portal Hypertension in LC

Study type

Observational

Funder types

Other

Identifiers

NCT03242135
17100264

Details and patient eligibility

About

role of RDW as anon invasive method for predicting liver cell failure & portal hypertension in cirrhotic patient

Full description

Red blood cell distribution width (RDW) is a measure of the range of variation of red blood cell (RBC) volume. The RDW-SD (Standard deviation ) is an actual measure of size. Normal reference range of RDW-SD in adult human is 39-46 fL .Liver plays an important role in removing body toxins which affects RBCs ,so liver cirrhosis may affects the RDW. Cirrhosis is a chronic degenerative disease in which irreversible scarring of the liver occurs. It leads to liver failure. Child's score is used as an indicator for liver cell function Portal hypertension is an increase in the blood pressure within the portal venous system .Obstruction to blood flow that occurs in liver due to fibrosis and regenerating nodules reduce flow from the portal veins into the hepatic veins. It also impedes hepatic artery flow from the branches that feed into the sinusoids. This increase in arterial resistance leads to an increase in arterial flow into the portal vein via producing a new anastamosis. The net result of that is an increase in portal vein pressure and dilatation of portal vein. Direct measurement of portal pressure is invasive, inconvenient, and clinically impractical. The Hepatic Venous Pressure Gradient (HVPG) is used to measure portal pressure .Recently, portal vein diameter is used as indicator for portal hypertension .

Enrollment

100 estimated patients

Sex

All

Ages

17 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

The study will include a total of 100 patient in Assiut university hospital diagnosed to be cirrhotic by abdominal US. They will be divided into 3 groups according to Child's score (A,B,C)

Exclusion criteria

  • Evidence of iron deficiency anaemia
  • Patients within one month of hematemesis
  • Thalassaemia

Trial contacts and locations

1

Loading...

Central trial contact

Marina Atef; AssiutU faculty of medicine, master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems